1.115 -0.015 (-1.33%) | 12-08 16:00 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 2.9 | 1-year : | 3.96 |
Resists | First : | 2.48 | Second : | 3.39 |
Pivot price | 1.17 ![]() |
|||
Supports | First : | 1.02 | Second : | 0.85 |
MAs | MA(5) : | 1.22 ![]() |
MA(20) : | 1.23 ![]() |
MA(100) : | 2.74 ![]() |
MA(250) : | 4.64 ![]() |
|
MACD | MACD : | -0.3 ![]() |
Signal : | -0.3 ![]() |
%K %D | K(14,3) : | 11.1 ![]() |
D(3) : | 20.3 ![]() |
RSI | RSI(14): 37.9 ![]() |
|||
52-week | High : | 8.21 | Low : | 1.02 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ MYNZ ] has closed above bottom band by 37.6%. Bollinger Bands are 59% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 1.21 - 1.22 | 1.22 - 1.22 |
Low: | 1.05 - 1.06 | 1.06 - 1.07 |
Close: | 1.1 - 1.11 | 1.11 - 1.12 |
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Wed, 06 Dec 2023
Mainz Biomeds ColoAlert A Groundbreaking Advancement in Colorectal Cancer Diagnostics - Best Stocks
Tue, 05 Dec 2023
Mainz Biomed Unveils Groundbreaking Findings on Enhanced ColoAlert for Colorectal Cancer Detection - Best Stocks
Mon, 27 Nov 2023
Where Will Mainz Biomed NV (MYNZ) Stock Go Next After It Is Down 5.79% in a Week? - InvestorsObserver
Fri, 24 Nov 2023
Mainz Biomed NV (MYNZ) Stock Falls -0.87% This Week; Should You Buy? - InvestorsObserver
Thu, 23 Nov 2023
FY2023 EPS Estimates for Mainz Biomed (NASDAQ:MYNZ) Raised by HC Wainwright - Defense World
Tue, 21 Nov 2023
Ceapro (OTCMKTS:CRPOF) and Mainz Biomed (NASDAQ:MYNZ) Critical Analysis - Defense World
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Diagnostics & Research
|
|
Shares Out | 0 (M) |
Shares Float | 20 (M) |
Held by Insiders | 1.478e+007 (%) |
Held by Institutions | 23.7 (%) |
Shares Short | 110 (K) |
Shares Short P.Month | 0 (K) |
EPS | -2.819e+007 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | -3 % |
Return on Assets (ttm) | 104.9 % |
Return on Equity (ttm) | -93.5 % |
Qtrly Rev. Growth | 874000 % |
Gross Profit (p.s.) | 127.1 |
Sales Per Share | -484.06 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | -2 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -22 (M) |
PE Ratio | -0.01 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | -0.01 |
Price to Cash Flow | 3.66 |
Dividend | 0 |
Forward Dividend | 138550 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |